OIS Podcast | Ophthalmology's leading Podcast • CEO John Kilcoyne Reviews ReVision’s Success with the FDA & its Plans to Roll Out Raindrop • Listen on Fountain
CEO John Kilcoyne Reviews ReVision’s Success with the FDA & its Plans to Roll Out Raindrop
ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.